HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Isolation and structure elucidation of a novel androgen antagonist, arabilin, produced by Streptomyces sp. MK756-CF1.

Abstract
In the course of screening for a new type of androgen receptor (AR) antagonist, we isolated a novel compound, arabilin, with two structural isomers, spectinabilin and SNF4435C, produced by Streptomyces sp. MK756-CF1. Structure elucidation on the basis of the spectroscopic properties showed that arabilin is a novel polypropionate-derived metabolite with a p-nitrophenyl group and a substituted γ-pyrone ring. Arabilin competitively blocked the binding of androgen to the ligand-binding domain of AR in vitro. In addition, arabilin inhibited androgen-induced prostate-specific antigen mRNA expression in prostate cancer LNCaP cells.
AuthorsTatsuro Kawamura, Takahiro Fujimaki, Natsuki Hamanaka, Kentaro Torii, Hiroki Kobayashi, Yoshikazu Takahashi, Masayuki Igarashi, Naoko Kinoshita, Yoshio Nishimura, Etsu Tashiro, Masaya Imoto
JournalThe Journal of antibiotics (J Antibiot (Tokyo)) Vol. 63 Issue 10 Pg. 601-5 (Oct 2010) ISSN: 1881-1469 [Electronic] England
PMID20736953 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Androgen Antagonists
  • Nitro Compounds
  • Pyrones
  • RNA, Messenger
  • SNF 4435C
  • arabilin
  • spectinabilin
  • Prostate-Specific Antigen
Topics
  • Androgen Antagonists (chemistry, isolation & purification, pharmacology)
  • Binding, Competitive
  • Cell Line, Tumor
  • Gene Expression Regulation, Neoplastic (drug effects)
  • Humans
  • Male
  • Nitro Compounds (isolation & purification)
  • Prostate-Specific Antigen (drug effects, genetics)
  • Prostatic Neoplasms (drug therapy, pathology)
  • Protein Binding
  • Pyrones (chemistry, isolation & purification, pharmacology)
  • RNA, Messenger (metabolism)
  • Spectrum Analysis (methods)
  • Stereoisomerism
  • Streptomyces (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: